BACKGROUND: On the basis of hypothesized protective effect, we examined the effect of soy foods on estrogens in nipple aspirate fluid (NAF) and serum, possible indicators of breast cancer risk. METHODS: In a crossover design, we randomized 96 women who produced 10 μL or more NAF to a high- or low-soy diet for 6 months. During the high-soy diet, participants consumed 2 soy servings of soy milk, tofu, or soy nuts (∼50 mg of isoflavones per day); during the low-soy diet, they maintained their usual diet. Six NAF samples were obtained using a FirstCyte aspirator. Estradiol (E(2)) and estrone sulfate (E(1)S) were assessed in NAF and estrone (E(1)) in serum only, using highly sensitive radioimmunoassays. Mixed-effects regression models accounting for repeated measures and left-censoring limits were applied. RESULTS:Mean E(2) and E(1)S were lower during the high-soy than the low-soy diet (113 vs. 313 pg/mL and 46 vs. 68 ng/mL, respectively) without reaching significance (P = 0.07); the interaction between group and diet was not significant. There was no effect of the soy treatment on serum levels of E(2) (P = 0.76), E(1) (P = 0.86), or E(1)S (P = 0.56). Within individuals, NAF and serum levels of E(2) (r(s) = 0.37; P < 0.001) but not of E(1)S (r(s) = 0.004; P = 0.97) were correlated. E(2) and E(1)S in NAF and serum were strongly associated (r(s) = 0.78 and r(s) = 0.48; P < 0.001). CONCLUSION:Soy foods in amounts consumed by Asians did not significantly modify estrogen levels in NAF and serum. IMPACT: The trend toward lower estrogen levels in NAF during the high-soy diet counters concerns about adverse effects of soy foods on breast cancer risk.
RCT Entities:
BACKGROUND: On the basis of hypothesized protective effect, we examined the effect of soy foods on estrogens in nipple aspirate fluid (NAF) and serum, possible indicators of breast cancer risk. METHODS: In a crossover design, we randomized 96 women who produced 10 μL or more NAF to a high- or low-soy diet for 6 months. During the high-soy diet, participants consumed 2 soy servings of soy milk, tofu, or soy nuts (∼50 mg of isoflavones per day); during the low-soy diet, they maintained their usual diet. Six NAF samples were obtained using a FirstCyte aspirator. Estradiol (E(2)) and estrone sulfate (E(1)S) were assessed in NAF and estrone (E(1)) in serum only, using highly sensitive radioimmunoassays. Mixed-effects regression models accounting for repeated measures and left-censoring limits were applied. RESULTS: Mean E(2) and E(1)S were lower during the high-soy than the low-soy diet (113 vs. 313 pg/mL and 46 vs. 68 ng/mL, respectively) without reaching significance (P = 0.07); the interaction between group and diet was not significant. There was no effect of the soy treatment on serum levels of E(2) (P = 0.76), E(1) (P = 0.86), or E(1)S (P = 0.56). Within individuals, NAF and serum levels of E(2) (r(s) = 0.37; P < 0.001) but not of E(1)S (r(s) = 0.004; P = 0.97) were correlated. E(2) and E(1)S in NAF and serum were strongly associated (r(s) = 0.78 and r(s) = 0.48; P < 0.001). CONCLUSION: Soy foods in amounts consumed by Asians did not significantly modify estrogen levels in NAF and serum. IMPACT: The trend toward lower estrogen levels in NAF during the high-soy diet counters concerns about adverse effects of soy foods on breast cancer risk.
Authors: D F Hargreaves; C S Potten; C Harding; L E Shaw; M S Morton; S A Roberts; A Howell; N J Bundred Journal: J Clin Endocrinol Metab Date: 1999-11 Impact factor: 5.958
Authors: Adrian A Franke; Jennifer F Lai; Brunhild M Halm; Ian Pagano; Naoko Kono; Wendy J Mack; Howard N Hodis Journal: J Nutr Biochem Date: 2011-07-19 Impact factor: 6.048
Authors: Robert T Chatterton; Angela S Geiger; Seema A Khan; Irene B Helenowski; Borko D Jovanovic; Peter H Gann Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-06 Impact factor: 4.254
Authors: Frank Z Stanczyk; Michael M Cho; David B Endres; John L Morrison; Stan Patel; Richard J Paulson Journal: Steroids Date: 2003-12 Impact factor: 2.668
Authors: Robert T Chatterton; Richard E Heinz; Angela J Fought; David Ivancic; Claire Shappell; Subhashini Allu; Susan Gapstur; Denise M Scholtens; Peter H Gann; Seema A Khan Journal: Horm Cancer Date: 2016-02-22 Impact factor: 3.869
Authors: Gertraud Maskarinec; Shana Suzuki; Ian S Pagano; Yukiko Morimoto; Adrian A Franke; Hormoz Ehya Journal: Nutr Cancer Date: 2013-10-15 Impact factor: 2.900
Authors: Yukiko Morimoto; Shannon M Conroy; Ian S Pagano; Adrian A Franke; Frank Z Stanczyk; Gertraud Maskarinec Journal: Food Funct Date: 2011-10-10 Impact factor: 5.396
Authors: Brook E Harmon; Yukiko Morimoto; Fanchon Beckford; Adrian A Franke; Frank Z Stanczyk; Gertraud Maskarinec Journal: Public Health Nutr Date: 2013-09-19 Impact factor: 4.022
Authors: G Maskarinec; Y Morimoto; S Heak; M Isaki; A Steinbrecher; L Custer; A A Franke Journal: Eur J Clin Nutr Date: 2012-06-20 Impact factor: 4.016
Authors: J S de Groot; C B Moelans; S G Elias; A Hennink; B Verolme; K P M Suijkerbuijk; A Jager; C Seynaeve; P Bos; A J Witkamp; M G E M Ausems; P J van Diest; E van der Wall Journal: PLoS One Date: 2015-05-22 Impact factor: 3.240
Authors: Jessica A Miller; Patricia A Thompson; Iman A Hakim; Ana Maria Lopez; Cynthia A Thomson; Chiu-Hsieh Hsu; H-H Sherry Chow Journal: Biomark Res Date: 2013-04-15